Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Cash from Investing Activities (2018 - 2026)

Viemed Healthcare filings provide 8 years of Cash from Investing Activities readings, the most recent being -$7.6 million for Q4 2025.

  • On a quarterly basis, Cash from Investing Activities rose 17.24% to -$7.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$50.2 million, a 63.41% decrease, with the full-year FY2025 number at -$50.2 million, down 63.41% from a year prior.
  • Cash from Investing Activities hit -$7.6 million in Q4 2025 for Viemed Healthcare, up from -$32.3 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of -$1.7 million in Q1 2021 to a low of -$32.3 million in Q3 2025.
  • Median Cash from Investing Activities over the past 5 years was -$7.0 million (2022), compared with a mean of -$8.8 million.
  • The widest YoY moves for Cash from Investing Activities: up 84.53% in 2025, down 549.97% in 2025.
  • Viemed Healthcare's Cash from Investing Activities stood at -$6.6 million in 2021, then dropped by 12.42% to -$7.4 million in 2022, then decreased by 1.56% to -$7.5 million in 2023, then dropped by 22.75% to -$9.2 million in 2024, then grew by 17.24% to -$7.6 million in 2025.
  • The last three reported values for Cash from Investing Activities were -$7.6 million (Q4 2025), -$32.3 million (Q3 2025), and -$1.7 million (Q2 2025) per Business Quant data.